Drug Profile


Alternative Names: AG-7088

Latest Information Update: 06 Aug 2009

Price : $50

At a glance

  • Originator Pfizer
  • Class Antivirals; Isoxazoles; Pyrrolidinones
  • Mechanism of Action Rhinovirus 3C protease inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Common cold

Most Recent Events

  • 12 Jan 2004 A study has been added to the Viral Infections therapeutic trials section
  • 05 Jun 2003 Suspended - Phase-II for Rhinovirus infections (Intranasal)
  • 06 Nov 2002 This compound is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top